Drug interactions for the following drug(s)
Applies to: fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters <> fluticasone propionate 50 MCG/INHAL Dry Powder Inhaler, 60 Blisters
Drug1 (rxcui = 896018, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug2 (rxcui = 896018, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler, tty = SCD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.